Implementation of guidelines for seasonal allergic rhinitis: a randomized controlled trial

Background: Allergic rhinitis is a common disease altering quality of life. Its treatment is well established and guidelines have been proposed. However, their efficacy has never been tested. The aim of the study was to validate the guidelines of the International Consensus on Rhinitis in the treatment of seasonal allergic rhinitis.

[1]  J. Bousquet,et al.  Effects of budesonide and fluticasone propionate in a placebo‐controlled study on symptoms and quality of life in seasonal allergic rhinitis , 2002, Allergy.

[2]  J. Bousquet,et al.  A revised nomenclature for allergy: An EAACI position statement from the EAACI nomenclature task force , 2001, Allergy.

[3]  J Bousquet,et al.  Consensus statement * on the treatment of allergic rhinitis , 2000, Allergy.

[4]  R. Mösges,et al.  International Conference on Allergic Rhinitis in Childhood , 1999 .

[5]  F. Simons,et al.  Allergic rhinobronchitis: the asthma-allergic rhinitis link. , 1999, The Journal of allergy and clinical immunology.

[6]  G. Guyatt,et al.  Generic and specific measurement of health-related quality of life in a clinical trial of respiratory rehabilitation. , 1999, Journal of clinical epidemiology.

[7]  U. Björnsdóttir,et al.  Asthma: an inflammatory mediator soup , 1999, Allergy.

[8]  J. Grimshaw,et al.  Potential benefits, limitations, and harms of clinical guidelines , 1999, BMJ.

[9]  R. Puy,et al.  Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials , 1998, BMJ.

[10]  S. Fineman,et al.  Executive Summary of Joint Task Force Practice Parameters on Diagnosis and Management of Rhinitis. , 1998, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[11]  S. Spector,et al.  Joint Task Force Algorithm and Annotations for Diagnosis and Management of Rhinitis. , 1998, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[12]  R. Dockhorn,et al.  Tri-Nasal Triamcinolone Acetonide Nasal Spray 200 and 400 μg qd versus Placebo and Nasacort Triamcinolone Acetonide Nasal Aerosol 440 μg qd in Patients Suffering from Seasonal Allergic Rhinitis during the Grass Season , 1998 .

[13]  Gene Feder,et al.  Guidelines for clinical guidelines , 1998, BMJ.

[14]  Davis,et al.  Symptom control in patients with hay fever in UK general practice: how well are we doing and is there a need for allergen immunotherapy? , 1998, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[15]  E. Meltzer,et al.  Allergic rhinitis: The patient's perspective , 1997 .

[16]  R. Eccles,et al.  An Evaluation of Nasal Response following Different Treatment Regimes of Oxymetazoline with Reference to Rebound Congestion , 1997, American journal of rhinology.

[17]  E. Juniper.  Measuring health-related quality of life in rhinitis. , 1997, The Journal of allergy and clinical immunology.

[18]  G. Guyatt,et al.  Interpretation of rhinoconjunctivitis quality of life questionnaire data. , 1996, The Journal of allergy and clinical immunology.

[19]  R. Pauwels,et al.  GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION , 1996 .

[20]  Simons Fe.  Learning impairment and allergic rhinitis. , 1996 .

[21]  J. H. Day,et al.  A randomized, double-blind, placebo-controlled, controlled antigen delivery study of the onset of action of aerosolized triamcinolone acetonide nasal spray in subjects with ragweed-induced allergic rhinitis. , 1996, The Journal of allergy and clinical immunology.

[22]  W. Busse,et al.  Comparison of triamcinolone acetonide nasal inhaler with astemizole in the treatment of ragweed-induced allergic rhinitis. , 1996, The Journal of allergy and clinical immunology.

[23]  D. Faulds,et al.  Ebastine , 1996, Drugs.

[24]  M. Alexander.  Comparative Therapeutic Studies with Tilavist , 1995, Allergy.

[25]  F. Simons,et al.  The pharmacology and use of H1-receptor-antagonist drugs. , 1994, The New England journal of medicine.

[26]  P. Venge,et al.  Soluble markers of allergic inflammation , 1994, Allergy.

[27]  International Rhinitis Management Working Group , 1994 .

[28]  K. Ennevaara,et al.  Double‐blind group comparative study of 2% nedocromil sodium eye drops with 2% sodium cromoglycate and placebo eye drops in the treatment of seasonal allergic conjunctivitis , 1992, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[29]  J. Bousquet,et al.  Double-blind, placebo-controlled rush immunotherapy with a standardized Alternaria extract. , 1990, The Journal of allergy and clinical immunology.

[30]  S. Ankier,et al.  A double‐blind placebo‐controlled study of the efficacy and tolerability of ebastine against hayfever in general practice patients , 1989, Journal of internal medicine.

[31]  A. Stewart,et al.  The MOS short-form general health survey. Reliability and validity in a patient population. , 1988, Medical care.

[32]  D. Faulds,et al.  Triamcinolone Acetonide , 1997, Drugs.

[33]  G. Langley,et al.  The visual analogue scale: Its use in pain measurement , 2004, Rheumatology International.

[34]  R. Dockhorn,et al.  Tri-Nasal triamcinolone acetonide nasal spray 200 and 400 micrograms qd versus placebo and Nasacort triamcinolone acetonide nasal aerosol 440 micrograms qd in patients suffering from seasonal allergic rhinitis during the grass season. , 1998, American journal of rhinology.

[35]  Valerie J. Lund,et al.  Infectious rhinosinusitis in adults: classification, etiology and management. International Rhinosinusitis Advisory Board. , 1997, Ear, nose, & throat journal.

[36]  F. Simons.  Learning impairment and allergic rhinitis. , 1996, Allergy and asthma proceedings.

[37]  G H Guyatt,et al.  Determining a minimal important change in a disease-specific Quality of Life Questionnaire. , 1994, Journal of clinical epidemiology.

[38]  E. Juniper,et al.  International Consensus Report on the diagnosis and management of rhinitis. International Rhinitis Management Working Group. , 1994, Allergy.